Pharmadrug Ownership
| LMLLF Stock | USD 0.01 0.0005 4.63% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Pharmadrug |
Pharmadrug Pink Sheet Ownership Analysis
The company has price-to-book ratio of 0.55. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pharmadrug recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 2nd of August 2016. Pharmadrug Inc. operates as a specialty pharmaceutical company. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Pharmadrug is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Pharmadrug contact Daniel Cohen at 647 202 1824 or learn more at https://www.pharmadrug.ca.Currently Active Assets on Macroaxis
Other Information on Investing in Pharmadrug Pink Sheet
Pharmadrug financial ratios help investors to determine whether Pharmadrug Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmadrug with respect to the benefits of owning Pharmadrug security.